BVMF/C1CO34 (BVMF/C1CO34)

Brazil Stock Exchange: BVMF/C1CO34 · BRL

R$776

+0.00 (0.0%)· Recorded snapshot

Market cap	332B
Revenue (ttm)	1.7T
Net income (ttm)	13.6B
EPS (ttm)	R$36.2
P/E (trailing)	21.4x
P/E (forward)	16.8x
Dividend	R$4.22 (0.54%)
Volume	0
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.7T
Net income (ttm): 13.6B
EPS (ttm): R$36.2
P/E (trailing): 21.4x
P/E (forward): 16.8x
Market cap: 332B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.8

P25 n/aP50 n/aP75 n/a

Trailing P/E21.4

P25 n/aP50 n/aP75 n/a

ROE96.9

P25 n/aP50 n/aP75 n/a

ROIC20.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/C1CO34 indicators

Market & fundamental data

Available fields

241

Groups with data

Currency

USD

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-04
Employees	51,000
Employees change	5,000
Employees growth	10.87%
Enterprise value	BRL 395.3B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Founded	1871
Industry	Medical Distribution
Is primary listing	No
ISIN number	BRC1COBDR008
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Market cap	BRL 332B
Next earnings date	2026-11-04
Price	BRL 775.73
Price currency	BRL
Sector	Healthcare
SIC code	5122
Stock price date	2026-09-30
Symbol	bvmf/C1CO34
Website	https://www.cencora.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	22.13x
Average P/E ratio (3Y)	28.29x
Average P/E ratio (5Y)	24.33x
Earnings yield	4.67%
EV/Earnings	29.07x
EV/EBIT	16.46x
EV/EBITDA	12.45x
EV/FCF	18.79x
EV/Sales	0.22x
FCF / EV yield	5.32%
FCF yield	6.34%
Forward P/E	16.78x
Graham number	167.42869
Graham upside	-78.42%
Lynch fair value	BRL 502.65
Lynch upside	-35.2%
P/(FCF - SBC) ratio	16.38x
P/(OCF - SBC) ratio	13.72x
P/B ratio	19.78x
P/E ratio	21.43x
P/FCF ratio	15.78x
P/OCF ratio	13.29x
P/S ratio	0.19x
Price/EBITDA ratio	11.55x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.35%
EBITDA margin	1.67%
Effective tax rate	26.82%
FCF margin	1.18%
Gross margin	3.96%
Operating margin	1.35%
Pretax margin	1.08%
Profit margin	0.79%
Profit per employee	BRL 277,521
Profitable quarters	3
Profitable years	5
Revenue per employee	BRL 35.2M
ROA	3.56%
ROA (5Y)	2.99%
ROCE	18.25%
ROE	96.87%
ROIC	20.95%
ROIC (5Y)	47.06%
SBC / revenue	0.04%
Tax / revenue	0.29%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	39.11%
EPS growth (Q)	11.93%
EPS growth (QoQ)	-53.1%
EPS growth 10Y	6.18%
EPS growth 3Y	18.02%
EPS growth quarters	3
EPS growth years	1
FCF growth	255.65%
FCF growth (QoQ)	106.99%
FCF growth 3Y	13.29%
FCF growth 5Y	9.63%
Gross profit growth	22.92%
Gross profit growth (Q)	24.3%
Gross profit growth 3Y	15.64%
Gross profit growth 5Y	16.8%
Net income growth	38.35%
Net income growth (Q)	11.07%
Net income growth (QoQ)	-53.48%
Net income growth 3Y	15.82%
Net income growth quarters	3
Net income growth years	1
OCF growth	176.74%
OCF growth (Q)	2,329.41%
OCF growth (QoQ)	98.27%
OCF growth 10Y	4.91%
OCF growth 3Y	14.06%
OCF growth 5Y	10.28%
Operating income growth	30.32%
Operating income growth (Q)	23.65%
Operating income growth 3Y	22.48%
Operating income growth 5Y	11.75%
Revenue growth	5.09%
Revenue growth (Q)	5.07%
Revenue growth (QoQ)	8.17%
Revenue growth 10Y	8.68%
Revenue growth 3Y	9.36%
Revenue growth 5Y	10.25%
Revenue growth quarters	56
Revenue growth years	13

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -3.9B
Depreciation and amortization	BRL 5.7B
EBIT	BRL 23.3B
EBITDA	BRL 28.7B
EPS	BRL 36.21
Financing cash flow	BRL 8.1B
Free cash flow	BRL 21B
Free cash flow minus SBC	BRL 20.3B
Gross profit	BRL 68.3B
Income taxes	BRL 5B
Investing cash flow	BRL -29.7B
Net borrowing	BRL 16.9B
Net cash flow	BRL 3.1B
Net income	BRL 13.6B
Operating cash flow minus SBC	BRL 24.2B
Operating income	BRL 23.3B
Revenue	BRL 1.7T
Stock-based compensation	BRL 770.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.7
Book value per share	BRL 82.83
Debt / EBITDA	2.44
Debt / equity	4.47
Debt / FCF	3.56
Goodwill	BRL 88.8B
Interest coverage	8.78
Long-term assets	BRL 136.5B
Long-term liabilities	BRL 99B
Net cash (debt)	BRL -60.3B
Net cash / market cap	-18.18%
Net debt / EBITDA	2.1
Net debt / equity	3.6
Net debt / FCF	2.87
Piotroski F-Score	6
Property, plant and equipment	BRL 15.3B
Shareholders' equity	BRL 16.8B
Tangible book value	BRL -100.5B
Tangible book value per share	BRL -526.57
Total assets	BRL 434.2B
Total cash	BRL 14.6B
Total debt	BRL 74.9B
Total liabilities	BRL 417.4B
WACC	6.55%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	4.22
Current assets	BRL 297.7B
Current liabilities	BRL 318.4B
Current ratio	0.93
Inventory turnover	15.53
Net working capital	BRL -30.9B
Quick ratio	0.48
Working capital	BRL -20B
Working capital turnover	-382.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.46%
Dividend growth	-1.24%
Dividend growth (3Y)	8.03%
Dividend growth (5Y)	5.84%
Dividend growth years	3
Dividend payment date	2026-09-04
Dividend payment years	7
Dividend payout frequency	Quarterly
Dividend per share	BRL 4.22
Dividend yield	0.54%
Ex-dividend date	2026-08-13
Last dividend	BRL 1.05
Payout ratio	17.83%
Shareholder yield	1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 667.25
1D price change	0%
1M price change	9.72%
1M total return	9.88%
1W price change	-2.18%
1W total return	-2.18%
1Y price change	-5.4%
1Y return CAGR	-4.92%
1Y total return	-4.91%
20-day SMA	BRL 815.47
200-day SMA	BRL 600.36
3M price change	9.72%
3M total return	9.88%
3Y price change	70.34%
3Y return CAGR	20.1%
3Y total return	73.27%
50-day SMA	BRL 848.22
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 960.00
52-week high date	2025-11-11
52-week low	BRL 665.32
52-week low date	2026-06-02
5Y price change	138.12%
5Y return CAGR	19.76%
5Y total return	146.31%
6M price change	-17.27%
6M total return	-17.04%
All-time high	BRL 960.00
All-time high date	2025-11-11
All-time low	BRL 181.90
All-time low date	2020-02-03
Average true range (ATR)	BRL 31.80
Average volume	10.9
Beta (5Y)	0.58
Change from 52-week high	-19.19%
Change from 52-week low	16.6%
Change from all-time high	-19.19%
Change from all-time low	326.46%
Change from open	0%
Day's gap	0%
High price	BRL 775.73
Low price	BRL 775.73
Monthly RSI	52.12
Open price	BRL 775.73
Previous close	BRL 775.73
Price vs 150-day SMA	16.26%
Price vs 20-day SMA	-4.87%
Price vs 200-day SMA	29.21%
Price vs 50-day SMA	-8.55%
Relative volume	0.18
RSI	44.5
Sharpe ratio	1.83
Sortino ratio	3.24
Volume	0
Weekly RSI	54.72
YTD price change	-18.34%
YTD total return	-18.02%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	180.3M
Shares change (QoQ)	-0.74%
Shares change (YoY)	-0.46%
Shares held by insiders	0.38%
Shares held by institutions	97.28%
Short ratio	3 days

Deeper analysis on BVMF/C1CO34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/C1CO34 report

Is a complete BVMF/C1CO34 research report available?

No complete published report is available for bvmf/C1CO34 (BVMF/C1CO34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/C1CO34 (BVMF/C1CO34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/C1CO34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/C1CO34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/C1CO34

Frequently asked questions